|
|
|
|
| LEADER |
01595nam a2200301 u 4500 |
| 001 |
EB001840328 |
| 003 |
EBX01000000000000001004317 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 928321272X
|
| 020 |
|
|
|a 9789283212720
|
| 050 |
|
4 |
|a RC268.57
|
| 245 |
0 |
0 |
|a Hormonal contraception and post-menopausal hormonal therapy
|h Elektronische Ressource
|c World Health Organization, International Agency for Research on Cancer
|
| 260 |
|
|
|a Lyon, France
|b IARC
|c 1999, 1999
|
| 300 |
|
|
|a x, 660 p.
|b ill.
|c 24 cm
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a Monographs -- Oral contraceptives, combined -- Hormonal contraceptives, progestogens only -- Post-menopausal oestrogen therapy -- Postmenopausal oestrogen-progestogen therapy -- Summary of final evaluations
|
| 653 |
|
|
|a Estrogen Replacement Therapy / adverse effects
|
| 653 |
|
|
|a Contraceptives, Oral, Hormonal / toxicity
|
| 710 |
2 |
|
|a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 710 |
2 |
|
|a International Agency for Research on Cancer
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a IARC monographs on the evaluation of carcinogenic risks to humans
|
| 500 |
|
|
|a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June 1998."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK396191
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 616.994071
|